Presentation TCT 2013 Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial) Presenter: John Puskas October 29, 2013
Presentation TCT 2013 Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR? Presenter: Larry Wood October 29, 2013
Presentation TCT 2013 Cell Therapy for Non-ST Elevation MI: A Phase 1 Study Presenter: Marc Penn October 29, 2013
Presentation TCT 2013 TCT-43. Impact Of Intraaortic Balloon Pump On 30-Day Mortality In Cardiogenic Shock AMI Patients With Unsuccessful And Successful Primary PCI - Analysis From PL-ACS Registry Presenter: Marek Gierlotka October 29, 2013
Presentation TCT 2013 TCT-47. Angiographic And Procedural Outcome Of Percutaneous Coronary Intervention With The STENTYS® Self-Apposing Coronary Stent In Patients Not Treated For STEMI. Presenter: Huangling Lu October 29, 2013
Presentation TCT 2013 Single Bolus Regadenoson Injection Versus Central Venous Infusion Of Adenosine To Induce Maximum Coronary Hyperemia For Measurement Of FFR Presenter: Lokien X. van Nunen October 29, 2013
Presentation TCT 2013 TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV... Presenter: Thierry Lefevre October 29, 2013